Beyond Medical Technologies Inc
XMUN:7FM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beyond Medical Technologies Inc
XMUN:7FM
|
CA |
|
Mistras Group Inc
F:MIY
|
US |
|
Iervolino & Lady Bacardi Entertainment SpA
F:G37
|
IT |
|
Vanguard Mining Corp
F:SL51
|
CA |
|
AroCell AB (publ)
F:80R
|
SE |
|
Granite Point Mortgage Trust Inc
F:G18
|
US |
|
W
|
Winchester Energy Ltd
OTC:WCHEF
|
AU |
|
N
|
Nippon Steel Corp
SWB:NPS
|
JP |
|
KDA Group Inc
F:O1M
|
CA |
|
Monster Arts Inc
OTC:APPZ
|
US |
|
Rainforest Resources Inc
OTC:RRIF
|
US |
|
G
|
G-III Apparel Group Ltd
XBER:GI4
|
US |
|
A
|
Alerio Gold Corp
CNSX:ALE
|
CA |
|
StarStream Entertainment Inc
OTC:SSET
|
US |
|
S
|
Scores Holding Company Inc
OTC:SCRH
|
US |
Income Statement
Earnings Waterfall
Beyond Medical Technologies Inc
Income Statement
Beyond Medical Technologies Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
1
+33%
|
0
N/A
|
1
N/A
|
1
-33%
|
0
-45%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
0
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
+50%
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(7)
|
(3)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(4)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(6)
N/A
|
(2)
+68%
|
(1)
+28%
|
(2)
-47%
|
(2)
+10%
|
(1)
+28%
|
(1)
+40%
|
(2)
-80%
|
(1)
+1%
|
(1)
+17%
|
(1)
+56%
|
(1)
+1%
|
(1)
+7%
|
(1)
+0%
|
(0)
+13%
|
(0)
+6%
|
(1)
-82%
|
(1)
-57%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
(4)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(6)
N/A
|
(6)
+2%
|
(2)
+70%
|
(3)
-37%
|
(2)
+9%
|
(2)
-2%
|
(1)
+65%
|
(2)
-80%
|
(1)
+1%
|
(1)
+17%
|
(1)
+55%
|
(1)
+1%
|
(0)
+20%
|
(0)
+1%
|
(0)
+15%
|
(0)
+25%
|
(2)
-776%
|
(2)
+11%
|
|
| Net Income | |||||||||||||||||||
| Income from Continuing Operations |
(6)
|
(6)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(6)
N/A
|
(6)
+2%
|
(3)
+54%
|
(3)
+12%
|
(2)
+7%
|
(2)
-2%
|
(1)
+42%
|
(2)
-50%
|
(2)
+5%
|
(2)
+13%
|
(1)
+66%
|
(1)
+2%
|
(0)
+22%
|
(0)
+0%
|
(0)
+37%
|
(0)
+32%
|
(2)
-1 133%
|
(2)
+11%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.79
-888%
|
-0.38
+52%
|
-0.32
+16%
|
-0.3
+6%
|
-0.3
N/A
|
-0.17
+43%
|
-0.26
-53%
|
-0.25
+4%
|
-0.22
+12%
|
-0.07
+68%
|
-0.07
N/A
|
-0.05
+29%
|
-0.05
N/A
|
-0.05
N/A
|
-0.03
+40%
|
-0.1
-233%
|
-0.08
+20%
|
|